S. Anjum, “Comparative effectiveness of cardiovascular, renal and safety outcomes of second-line antidiabetic drugs use in people with type 2 diabetes”, HOM, vol. 10, no. 2, pp. 1270–1279, Apr. 2024, doi: 10.17720/h7ycmf16.